Use of a pak inhibitor for the treatment of a joint disease
摘要
The invention refers to the use of a p21-activated kinase (PAK) inhibitor for the treatment of a joint disease such as osteoarthritis or rheumatoid arthritis or for the treatment of a joint pain and the use of PAK as a target protein for the discovery of a PAK inhibitor as a medicament for the treatment of a joint disease.
申请公布号
EP1498133(A1)
申请公布日期
2005.01.19
申请号
EP20030016303
申请日期
2003.07.18
申请人
AVENTIS PHARMA DEUTSCHLAND GMBH
发明人
BARRADEAU, SEBASTIAN, DR.;BARTNIK, ECKART, DR.;CZECH, JOERG, DR.;KLATT, ANDREAS R., DR.;LEBERER, EKKEHARD, PROF. DR.;LEEUW, THOMAS, DR.
